|
|
|
Insider
Information: |
Bybee Clinton |
Relationship: |
10% Owner |
City: |
Chicago |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
37,071,986 |
|
Indirect Shares
|
66,802,916 |
|
|
Direct
Value |
$345,457,020 |
|
|
Indirect Value
|
$765,257,385 |
|
|
Total
Shares |
103,874,902 |
|
|
Total
Value |
$1,110,714,405 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-22.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Illumina Inc |
ILMN |
Former 10% Holder |
2004-02-03 |
5,704 |
2004-02-03 |
2,915,298 |
Premium* |
|
Alnylam Pharmaceuticals Inc |
ALNY |
10% Owner |
|
0 |
2004-05-27 |
222,500 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
2004-03-19 |
0 |
2004-03-19 |
2,054,271 |
Premium* |
|
Kythera Biopharmaceuticals Inc |
KYTH |
10% Owner |
2012-10-16 |
2,105,740 |
2012-10-16 |
0 |
Premium* |
|
Fate Therapeutics Inc |
FATE |
10% Owner |
2013-10-04 |
2,473,188 |
2013-10-04 |
0 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
10% Owner |
2015-02-19 |
3,088,590 |
2014-06-23 |
0 |
Premium* |
|
Sage Therapeutics, Inc. |
SAGE |
10% Owner |
2015-06-18 |
2,124,699 |
2014-07-23 |
0 |
Premium* |
|
Juno Therapeutics, Inc. |
JUNO |
10% Owner |
2016-03-15 |
10,552,390 |
|
0 |
Premium* |
|
Bellerophon Therapeutics Inc |
BLPH |
10% Owner |
2015-02-19 |
965,660 |
|
0 |
Premium* |
|
Xtera Communications, Inc. |
XCOM |
Director, 10% Owner |
|
0 |
2015-11-17 |
1,885,090 |
Premium* |
|
Syros Pharmaceuticals, Inc. |
SYRS |
10% Owner |
2016-07-06 |
4,637,137 |
|
0 |
Premium* |
|
Impinj Inc |
PI |
Director |
2020-10-23 |
17,125 |
2019-11-15 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
10% Owner |
2017-12-12 |
11,068,749 |
2017-12-12 |
0 |
Premium* |
|
Unity Biotechnology Inc |
UBX |
10% Owner |
2018-05-07 |
0 |
2018-05-07 |
1,682,417 |
Premium* |
|
Gossamer Bio Inc |
GOSS |
10% Owner |
2019-02-12 |
0 |
2019-02-12 |
4,027,958 |
Premium* |
|
Karuna Therapeutics, Inc. |
KRTX |
10% Owner |
2019-07-02 |
0 |
2019-07-02 |
1,681,435 |
Premium* |
|
Beam Therapeutics Inc. |
BEAM |
10% Owner |
2021-03-31 |
2,434 |
2021-03-31 |
3,521,519 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
10% Owner |
2022-09-06 |
30,570 |
2022-09-06 |
61,160 |
Premium* |
|
Lyell Immunopharma, Inc. |
LYEL |
10% Owner |
2021-06-21 |
0 |
2021-06-21 |
18,206,358 |
Premium* |
|
Neumora Therapeutics, Inc. |
NMRA |
10% Owner |
|
0 |
2023-12-08 |
30,544,910 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
115 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PI |
Impinj Inc |
Director |
|
2016-07-26 |
4 |
OE |
$9.32 |
$373,042 |
I/I |
40,026 |
1,388,049 |
0 |
- |
|
PI |
Impinj Inc |
Director |
|
2016-07-26 |
4/A |
D |
$14.00 |
$298,382 |
I/I |
(21,313) |
1,366,735 |
0 |
- |
|
PI |
Impinj Inc |
Director |
|
2016-07-26 |
4/A |
OE |
$7.46 |
$298,587 |
I/I |
40,025 |
1,388,048 |
0 |
- |
|
PI |
Impinj Inc |
Director |
|
2017-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
417 |
417 |
0 |
- |
|
PI |
Impinj Inc |
Director |
|
2019-05-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(301,976) |
1,064,759 |
0 |
- |
|
PI |
Impinj Inc |
Director |
|
2019-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
557 |
6,997 |
0 |
- |
|
PI |
Impinj Inc |
Director |
|
2019-07-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(322,158) |
742,601 |
0 |
- |
|
PI |
Impinj Inc |
Director |
|
2019-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
596 |
7,593 |
0 |
- |
|
PI |
Impinj Inc |
Director |
|
2019-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
610 |
12,957 |
0 |
- |
|
PI |
Impinj Inc |
Director |
|
2019-08-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(331,781) |
410,820 |
0 |
- |
|
PI |
Impinj Inc |
Director |
|
2019-11-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(410,820) |
0 |
0 |
- |
|
PI |
Impinj Inc |
Director |
|
2019-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
757 |
13,714 |
0 |
- |
|
PI |
Impinj Inc |
Director |
|
2020-10-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,411 |
17,125 |
0 |
- |
|
ILMN |
Illumina Inc |
Former 10% Holder |
|
2004-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
616 |
5,704 |
|
- |
|
ILMN |
Illumina Inc |
Former 10% Holder |
|
2004-02-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(400,000) |
2,915,298 |
|
- |
|
115 Records found
|
|
Page 5 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|